The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in ...
A need exists for alternate or supplemental treatment modalities, particularly those that neutralize anthrax toxins. The focus has been on passive immunization with monoclonal and polyclonal ...
More information: An antibody–toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy, Nature Cancer (2025). DOI: 10.1038/s43018-025-00919-0 Journal ...